SEATTLE CHILDREN'S HOSPITAL (DBA SEATTLE CHILDREN'S RESEARCH INSTITUTE
发明人:
PORTMAN, MICHAEL A.
申请号：
CA3042126
公开号：
CA3042126A1
申请日:
2019.05.02
申请国别(地区):
CA
年份:
2019
代理人:
摘要：
The present invention relates to the discovery that etanercept reduces therate ofresistance to intravenous gamma globulin (IVIG) in subjects with acuteKawasaki disease (KD).In certain embodiments, the co-administration of etanercept and IVIG moreeffectively treatsacute KD in subjects older than 12 months than IVIG alone. In otherembodiments, theco-administration of etanercept and IVIG ameliorates coronary artery dilationin high risk subjects.
